204 related articles for article (PubMed ID: 35916996)
1. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation.
Inoue Y; Tasaki M; Masuda T; Misumi Y; Nomura T; Ando Y; Ueda M
Cell Mol Life Sci; 2022 Aug; 79(8):462. PubMed ID: 35916996
[TBL] [Abstract][Full Text] [Related]
2. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y
Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503
[TBL] [Abstract][Full Text] [Related]
3. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
Haglund M; Kalaria R; Slade JY; Englund E
Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
[TBL] [Abstract][Full Text] [Related]
4. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus.
Inoue Y; Masuda T; Misumi Y; Ando Y; Ueda M
Neurosci Lett; 2021 Sep; 762():136136. PubMed ID: 34311050
[TBL] [Abstract][Full Text] [Related]
6. Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression.
Inoue Y; Ueda M; Masuda T; Misumi Y; Yamashita T; Ando Y
Mol Neurobiol; 2019 Dec; 56(12):8573-8588. PubMed ID: 31280448
[TBL] [Abstract][Full Text] [Related]
7. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
[TBL] [Abstract][Full Text] [Related]
8. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
[TBL] [Abstract][Full Text] [Related]
9. MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.
Marazuela P; Solé M; Bonaterra-Pastra A; Pizarro J; Camacho J; Martínez-Sáez E; Kuiperij HB; Verbeek MM; de Kort AM; Schreuder FHBM; Klijn CJM; Castillo-Ribelles L; Pancorbo O; Rodríguez-Luna D; Pujadas F; Delgado P; Hernández-Guillamon M
Acta Neuropathol Commun; 2021 Sep; 9(1):154. PubMed ID: 34530925
[TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
11. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
12. Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells.
Van Nostrand WE; Melchor JP
Amyloid; 2001 Jul; 8 Suppl 1():20-7. PubMed ID: 11676286
[TBL] [Abstract][Full Text] [Related]
13. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
Xiong M; Wang C; Gratuze M; Saadi F; Bao X; Bosch ME; Lee C; Jiang H; Serrano JR; Gonzales ER; Kipnis M; Holtzman DM
Mol Neurodegener; 2023 Mar; 18(1):17. PubMed ID: 36922879
[TBL] [Abstract][Full Text] [Related]
14. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.
Al-Shawi R; Tennent GA; Millar DJ; Richard-Londt A; Brandner S; Werring DJ; Simons JP; Pepys MB
Open Biol; 2016 Feb; 6(2):150202. PubMed ID: 26842068
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging.
Prada CM; Garcia-Alloza M; Betensky RA; Zhang-Nunes SX; Greenberg SM; Bacskai BJ; Frosch MP
J Neurosci; 2007 Feb; 27(8):1973-80. PubMed ID: 17314293
[TBL] [Abstract][Full Text] [Related]
18. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
19. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
20. Intracisternal injection of beta-amyloid seeds promotes cerebral amyloid angiopathy.
Yuan Q; Xian YF; Huang YF; Wu W; Song YQ; Lin ZX
Brain Behav Immun; 2020 Oct; 89():628-640. PubMed ID: 32739364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
